INVENTRONICS LTD (IVX.CA) Fundamental Analysis & Valuation

TSX-V:IVX • CA4612082095

Current stock price

0.8 CAD
+0.05 (+6.67%)
Last:

This IVX.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. IVX.CA Profitability Analysis

1.1 Basic Checks

  • IVX had positive earnings in the past year.
  • In the past year IVX had a positive cash flow from operations.
  • IVX had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years IVX had a positive operating cash flow.
IVX.CA Yearly Net Income VS EBIT VS OCF VS FCFIVX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M 2M 3M

1.2 Ratios

  • IVX has a better Return On Assets (3.06%) than 100.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 7.03%, IVX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • IVX has a better Return On Invested Capital (5.32%) than 100.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for IVX is significantly above the industry average of 5.32%.
  • The last Return On Invested Capital (5.32%) for IVX is well below the 3 year average (16.93%), which needs to be investigated, but indicates that IVX had better years and this may not be a problem.
Industry RankSector Rank
ROA 3.06%
ROE 7.03%
ROIC 5.32%
ROA(3y)13.23%
ROA(5y)18.83%
ROE(3y)27.58%
ROE(5y)43.53%
ROIC(3y)16.93%
ROIC(5y)16.61%
IVX.CA Yearly ROA, ROE, ROICIVX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

  • The Profit Margin of IVX (2.38%) is better than 100.00% of its industry peers.
  • IVX has a Operating Margin of 4.99%. This is amongst the best in the industry. IVX outperforms 100.00% of its industry peers.
  • IVX's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 19.10%, IVX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • IVX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.99%
PM (TTM) 2.38%
GM 19.1%
OM growth 3Y-64.43%
OM growth 5Y-35.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.48%
GM growth 5Y-3.82%
IVX.CA Yearly Profit, Operating, Gross MarginsIVX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. IVX.CA Health Analysis

2.1 Basic Checks

  • IVX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for IVX remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for IVX has been increased compared to 5 years ago.
  • IVX has a better debt/assets ratio than last year.
IVX.CA Yearly Shares OutstandingIVX.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
IVX.CA Yearly Total Debt VS Total AssetsIVX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • IVX has an Altman-Z score of 2.76. This is not the best score and indicates that IVX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.76, IVX is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • IVX has a debt to FCF ratio of 4.04. This is a neutral value as IVX would need 4.04 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 4.04, IVX is doing worse than 66.67% of the companies in the same industry.
  • A Debt/Equity ratio of 0.77 indicates that IVX is somewhat dependend on debt financing.
  • IVX has a Debt to Equity ratio of 0.77. This is in the lower half of the industry: IVX underperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 4.04
Altman-Z 2.76
ROIC/WACC0.62
WACC8.59%
IVX.CA Yearly LT Debt VS Equity VS FCFIVX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.3 Liquidity

  • IVX has a Current Ratio of 2.65. This indicates that IVX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.65, IVX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • IVX has a Quick Ratio of 1.88. This is a normal value and indicates that IVX is financially healthy and should not expect problems in meeting its short term obligations.
  • IVX has a Quick ratio of 1.88. This is amongst the best in the industry. IVX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.65
Quick Ratio 1.88
IVX.CA Yearly Current Assets VS Current LiabilitesIVX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. IVX.CA Growth Analysis

3.1 Past

  • IVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 825.93%, which is quite impressive.
  • Looking at the last year, IVX shows a very strong growth in Revenue. The Revenue has grown by 35.07%.
  • Measured over the past years, IVX shows a small growth in Revenue. The Revenue has been growing by 2.21% on average per year.
EPS 1Y (TTM)825.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%259.38%
Revenue 1Y (TTM)35.07%
Revenue growth 3Y-13.78%
Revenue growth 5Y2.21%
Sales Q2Q%29.55%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IVX.CA Yearly Revenue VS EstimatesIVX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

Find the best growth stocksShow best growing peers

4

4. IVX.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • IVX is valuated rather expensively with a Price/Earnings ratio of 20.00.
  • Based on the Price/Earnings ratio, IVX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • IVX's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.11.
Industry RankSector Rank
PE 20
Fwd PE N/A
IVX.CA Price Earnings VS Forward Price EarningsIVX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IVX is valued cheaper than 100.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, IVX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.86
EV/EBITDA 8.64
IVX.CA Per share dataIVX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • IVX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. IVX.CA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 23.33%, IVX is a good candidate for dividend investing.
  • IVX's Dividend Yield is rather good when compared to the industry average which is at 7.78. IVX pays more dividend than 100.00% of the companies in the same industry.
  • IVX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 23.33%

5.2 History

  • IVX has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IVX.CA Yearly Dividends per shareIVX.CA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
IVX.CA Yearly Income VS Free CF VS DividendIVX.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K 1M 1.5M 2M

More info and screens

Find the best dividend stocksShow peers with best dividend

IVX.CA Fundamentals: All Metrics, Ratios and Statistics

INVENTRONICS LTD

TSX-V:IVX (3/16/2026, 7:00:00 PM)

0.8

+0.05 (+6.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners8.93%
Ins Owner ChangeN/A
Market Cap3.90M
Revenue(TTM)8.02M
Net Income(TTM)191.00K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 23.33%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 20
Fwd PE N/A
P/S 0.49
P/FCF 6.86
P/OCF 6.16
P/B 1.43
P/tB 1.43
EV/EBITDA 8.64
EPS(TTM)0.04
EY5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.12
FCFY14.58%
OCF(TTM)0.13
OCFY16.22%
SpS1.65
BVpS0.56
TBVpS0.56
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.71
Profitability
Industry RankSector Rank
ROA 3.06%
ROE 7.03%
ROCE 7.89%
ROIC 5.32%
ROICexc 6.85%
ROICexgc 6.85%
OM 4.99%
PM (TTM) 2.38%
GM 19.1%
FCFM 7.08%
ROA(3y)13.23%
ROA(5y)18.83%
ROE(3y)27.58%
ROE(5y)43.53%
ROIC(3y)16.93%
ROIC(5y)16.61%
ROICexc(3y)18.71%
ROICexc(5y)18%
ROICexgc(3y)18.71%
ROICexgc(5y)18%
ROCE(3y)25.1%
ROCE(5y)24.63%
ROICexgc growth 3Y-68.88%
ROICexgc growth 5Y-39.12%
ROICexc growth 3Y-68.88%
ROICexc growth 5Y-39.12%
OM growth 3Y-64.43%
OM growth 5Y-35.81%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.48%
GM growth 5Y-3.82%
F-Score7
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 4.04
Debt/EBITDA 3.59
Cap/Depr 34.41%
Cap/Sales 0.8%
Interest Coverage 2.86
Cash Conversion 107.85%
Profit Quality 297.38%
Current Ratio 2.65
Quick Ratio 1.88
Altman-Z 2.76
F-Score7
WACC8.59%
ROIC/WACC0.62
Cap/Depr(3y)281.39%
Cap/Depr(5y)239.45%
Cap/Sales(3y)5.39%
Cap/Sales(5y)4.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)825.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%259.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)35.07%
Revenue growth 3Y-13.78%
Revenue growth 5Y2.21%
Sales Q2Q%29.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y250.88%
EBIT growth 3Y-69.33%
EBIT growth 5Y-34.39%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.83%
FCF growth 3Y-16.33%
FCF growth 5Y11.05%
OCF growth 1Y-75.44%
OCF growth 3Y-11.65%
OCF growth 5Y14.04%

INVENTRONICS LTD / IVX.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of INVENTRONICS LTD (IVX.CA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to IVX.CA.


What is the valuation status for IVX stock?

ChartMill assigns a valuation rating of 4 / 10 to INVENTRONICS LTD (IVX.CA). This can be considered as Fairly Valued.


How profitable is INVENTRONICS LTD (IVX.CA) stock?

INVENTRONICS LTD (IVX.CA) has a profitability rating of 7 / 10.


What is the valuation of INVENTRONICS LTD based on its PE and PB ratios?

The Price/Earnings (PE) ratio for INVENTRONICS LTD (IVX.CA) is 20 and the Price/Book (PB) ratio is 1.43.


Is the dividend of INVENTRONICS LTD sustainable?

The dividend rating of INVENTRONICS LTD (IVX.CA) is 5 / 10 and the dividend payout ratio is 0%.